Operationalizing Adaptive Design For FDA's One-Trial Era

The FDA now accepts one pivotal trial as the default path to approval. Learn how adaptive designs can help you build a single study strong enough to stand on its own.

Scaling Pharmacovigilance: Clinical Development To Commercialization

Commercial growth brings new PV challenges. Gain practical insights on operating models, technology, governance, and leadership for long-term success.

Speed Meets Precision: Accelerating Oncology With Smarter Data

This webinar will explore how oncology sponsors are modernizing data flow, analytics, and cross-functional collaboration to support faster, more informed trial decisions without compromising quality.

What's Actually Working In AI-Enabled Respiratory Trials

The Evidence Gap In Hematology: From Trial Endpoints To Patient Outcomes

Hematology trials face shrinking patient pools and fierce competition. Discover how real-world data and evidence can sharpen feasibility, site selection, and regulatory strategy.

AI Reality Check In Drug Development: What's Real And What's Missing

Where does AI actually add value in drug development—and where does human expertise still matter? Explore practical answers for trial teams navigating the hype.

Optimizing Movement Disorder Clinical Trials: A Focus On Parkinson's Disease

Join DVCR experts for a presentation on designing effective Parkinson's clinical trials. This webinar covers endpoint selection, patient-centered design, and real-world case studies.

Where Precision Drives Progress: Meeting The Rising Complexity Of Modern Clinical Trials

Discover how leading teams are using trusted data and targeted AI to design, plan, and execute clinical trials with the confidence today's science requires.

IRB In Action: A Live Mock Board Review

Experience a live mock IRB review! Watch industry experts evaluate a fictional protocol to uncover insights into board decision-making, master the review process, and improve your future submissions.

Rewriting The Code: Advances And Challenges In Pediatric Gene Therapy

This presentation examines pediatric gene therapy and the three platforms now driving clinical progress: AAV vectors, lentiviral vectors, and CRISPR-based gene editing.

The Hidden Cost Of CRO Change Orders And How Sponsors Can Best Manage Them

Improve budget oversight, forecast costs more accurately, and maintain a clear audit trail to minimize surprises and streamline CRO change orders.

The Site AI Playbook: Vendor Tools, Homegrown Solutions & What's Working

Gain a practical framework for evaluating tools, identifying high-impact use cases, and making informed decisions about implementation and vendor selection.

Accelerating Clinical Data Review Without Losing Control

Faster clinical review requires more than automation. See how governed AI can help teams spot issues sooner and preserve trust, transparency, and expert control throughout decision-making.

How Humans And AI Collaborate To Improve Quality, Speed, And Agility In Study Build

Learn how combining human expertise with AI can improve speed, consistency, and oversight while identifying issues earlier and supporting higher-quality clinical trial execution.

The True Science Behind eCOA, Shaped By Patient And Site Insights

This webinar brings together patients, sites, and eCOA science to dismantle the researcher-subject hierarchy and replace it with a collaborative model.

From First Click To Randomization: Improving Patient Qualification In Psychiatry Trials

How can you, as a sponsor, optimize recruitment workflows, enhance patient screening, and ensure sites receive higher-quality patients?

The Stakeholder Impact of Centralized Trial Services

Real‑world experiences show how centralizing logistics and payments streamlines coordination, reduces site burden, and improves trial execution.

Integrating Clinical Operations And Pharmacovigilance for Safer Trials

Learn how integrated planning strengthens decision-making, reduces downstream risk, and supports patient safety while protecting timelines in high-risk studies.

AI Meets Informed Consent: Opportunity, Risk, And What IRBs Need To See

Expert perspectives on IRB oversight, health literacy, and research ethics offer practical guidance to strengthen consent, protect participants, and align compliance with real-world research.

Applying AI to Study Simulation: From Design to Analysis

See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.

Execution Without Direction: The Hidden Risk In Outsourced Clinical Trials

Follow along as industry experts unpack the underlying causes of these challenges and consider whether clinical oversight monitors represent a necessary evolution or simply an additional layer of complexity.

How To Improve Patient ID And Retention In Chronic Disease Trials

Leveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.

We Mapped What Sites Actually Do To Prepare Source Docs - The Results Are Eye-Opening

New global research shows how sites prepare source documents, where inefficiencies occur, and why workflows differ — highlighting ways to streamline processes, cut delays, and improve data quality.

The Phase 2 Endpoint Dilemma

Phase 2 neuro endpoints can miss subtle change. Learn when composites help or hinder, how to align cognition, function, and biomarkers with real-world data for go/no-go decisions.

Qualified eSignature in Electronic Consent Systems

This on‑demand session offers a clear, practical overview of the major eSignature types used in eConsent — ranging from simple electronic signatures to fully qualified electronic signatures — and explains when each is appropriate.

Charting The Path To First-In-Human: Strategic Readiness For Early Clinical Success

Gain a comprehensive, end-to-end perspective on the journey to first-in-human and understand how early decisions influence downstream success.

Embedding AI And Critical IRB Operations Data To Drive Intelligent Study Design

Explore how modern clinical trial design is being transformed by a rich array of data sources through this clear roadmap for navigating the evolving complexities of the industry.

CRO Selection Science: Insights From $2B+ Vendor Choices

Discover how data-driven strategies and structured RFPs can simplify CRO selection, improve transparency, and ensure the right operational fit. Learn practical steps to make smarter vendor decisions.

Should Sponsors Provide Source Document Templates?

Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.

EU GMP Annex 11: Compliance Strategy And Digital Solutions

Explore how EU GMP Annex 11 revisions could reshape global pharmaceutical compliance, as well as strategies for navigating implementation challenges and building future-ready validation programs.